APA (7th ed.) Citation

Schulz, M., Kieble, M., Enners, S., Laufs, U., Böhm, M., Kintscher, U., & Mahfoud, F. (2020). PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE. Value in Health, 23, S102. https://doi.org/10.1016/j.jval.2020.04.167

Chicago Style (17th ed.) Citation

Schulz, M., M. Kieble, S. Enners, U. Laufs, M. Böhm, U. Kintscher, and F. Mahfoud. "PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE." Value in Health 23 (2020): S102. https://doi.org/10.1016/j.jval.2020.04.167.

MLA (9th ed.) Citation

Schulz, M., et al. "PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE." Value in Health, vol. 23, 2020, p. S102, https://doi.org/10.1016/j.jval.2020.04.167.